GTC Biotherapeutics (fka GTCB)

[voodoo in my basemen]

<<From Dr. Cox’s remarks on the 2Q07 CC (emphasis added):>>........

<< large, well financed, commercial partner is an important objective for GTC to achieve the market presence and opportunity which we believe ATryn represents, and I look forward to updating you on our progress.>>

Dew et all,

not that much forecast value;
but at which stage was partnering in Europe announced?
Was it end of phase II or just before/after filing?

What are the assets both for partner as well for the company?

V.